Dr Ivor Elrifi is a partner in the Cooley Litigation department and Chair of the Patent Counseling & Prosecution practice group. He joined the firm in 2014 and is resident in the New York and Boston offices.
Dr Elrifi advises pharmaceutical, biotechnology, life sciences, and medical device companies, research institutions, universities, hospitals, and governments throughout the world. He has worked with clients in the United States as well as in Europe. His practice includes patent prosecution, litigation, arbitration, licensing, and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations, and medical devices.
Dr Elrifi counsels clients worldwide in developing and implementing patent strategies and in the prosecution, licensing, and enforcement of patents. He has extensive experience in advising clients on transactional work and regularly counsels clients with respect to investments, mergers, and acquisitions. He has also advised plaintiffs and defendants in patent litigation and arbitration cases.
He has spoken at numerous international conferences, and has written numerous articles for leading legal and scientific publications.
Prior to joining Cooley, Dr Elrifi was Co-chair and Section Manager of Mintz Levin's national Intellectual Property practice. Earlier in his career, Dr Elrifi served as patent counsel and then general counsel and vice president for CytoTherapeutics, Inc. in Providence, Rhode Island, and as patent counsel to Modex Therapeutics in Lausanne, Switzerland.
Dr Elrifi earned his law degree from Osgoode Hall Law School. He obtained his PhD and BS in Biology from Queen's University.
Dr Elrifi is a member of the California, Massachusetts, and New York State Bars, a member of the Ontario Canada Bar and is admitted to the US Patent and Trademark Office.